Ozone Pharmaceuticals CMD launches his latest book 13 Prescriptions for Success in Life

New Delhi: SC Sehgal, Chairman and Managing Director of Ozone Pharmaceuticals, unveiled his much-awaited book 13 Prescriptions for Success in Life at Le Meridien, New Delhi, on Thursday. Published by Notion Press, the book was officially released on August 27 across major e-commerce platforms, including Notionpress.com.

Drawing upon decades of entrepreneurial leadership and personal reflection, Sehgal distilled his philosophy that “to succeed you need strength, but to sustain success you need humility.” The work, positioned as much a guide for boardrooms as for life, encapsulates learnings gathered through experience, setbacks, and growth.

The launch was graced by Dr. Kiran Bedi, India’s first woman IPS officer, who attended as Chief Guest. Lauding the book, she said, “The outlook for any enterprise must be growth with service, not status. Power is best reflected in the way it serves people, not in the position it commands. This book is filled with quotable quotes that, when reread daily, offer new perspective. I hope Ozone grows by leaps and bounds, becomes synonymous with Make in India and Make for the World, and continues to generate employment, service, and pride for the nation.”

Sehgal described the work as “not prescriptions from a pedestal, but experiential learning.” He emphasized that the book is a humble attempt to provide readers with a compass to grow with discipline, service, and purpose.

From a modest beginning, Sehgal has steered Ozone Pharmaceuticals into one of India’s most respected pharma companies. With revenues poised to reach Rs 1,000 crore, Ozone today symbolizes the Make in India dream—Indian in heart, global in vision. That same ethos informs the book: success means responsibility to create lasting impact and legacy.

Related Posts

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Hetero debuts semaglutide generic in emerging markets

New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework